Preise & Rabatte einsehen
Geschenke sichern
Angebote anfragen & online annehmen
Cell Biology
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E3 ubiquitin-protein ligase RNF168(RNF168) | Anmelden | E3 ubiquitin-protein ligase RNF168(RNF168) | ||||||||||||||||
|
||||||||||||||||||
| E3 ubiquitin-protein ligase TRIM33(TRIM33) | Anmelden | E3 ubiquitin-protein ligase TRIM33(TRIM33) | ||||||||||||||||
|
||||||||||||||||||
| Fibronectin(FN1) HTA | Anmelden | Fibronectin(FN1) HTA | ||||||||||||||||
|
||||||||||||||||||
| Interleukin-1 alpha(IL1A）His Tag | Anmelden | Interleukin-1 alpha(IL1A）His Tag | ||||||||||||||||
|
||||||||||||||||||
| Interleukin-5(IL5) | Anmelden | Interleukin-5(IL5) | ||||||||||||||||
|
||||||||||||||||||
| PCNA protein / Proliferating cell nuclear antigen | Anmelden | PCNA protein / Proliferating cell nuclear antigen | ||||||||||||||||
|
||||||||||||||||||
| Anti-IL17A/TNFSF13B/CD257(Homo sapiens) (Tibulizumab) Monoclonal Antibody | Anmelden | Anti-IL17A/TNFSF13B/CD257(Homo sapiens) (Tibulizumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-IL17A/TNFSF13B/CD257(Homo sapiens) (Tibulizumab) Monoclonal Antibody | Anmelden | Anti-IL17A/TNFSF13B/CD257(Homo sapiens) (Tibulizumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Pimivalimab Biosimilar - Anti-PDCD1 mAb - Research Grade | Anmelden | Pimivalimab Biosimilar - Anti-PDCD1 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Anti-ANGPT2/VEGFA(Homo sapiens) (Faricimab) Monoclonal Antibody | Anmelden | Anti-ANGPT2/VEGFA(Homo sapiens) (Faricimab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-KDR/VEGFR2(Homo sapiens) (Olinvacimab) Monoclonal Antibody | Anmelden | Anti-KDR/VEGFR2(Homo sapiens) (Olinvacimab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-DLL4/VEGFA(Homo sapiens) (Dilpacimab) Monoclonal Antibody | Anmelden | Anti-DLL4/VEGFA(Homo sapiens) (Dilpacimab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-DLL4/VEGFA(Homo sapiens) (Dilpacimab) Monoclonal Antibody | Anmelden | Anti-DLL4/VEGFA(Homo sapiens) (Dilpacimab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Torudokimab Biosimilar - Anti-IL33 mAb - Research Grade | Anmelden | Torudokimab Biosimilar - Anti-IL33 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Tozorakimab Biosimilar - Anti-IL33 mAb - Research Grade | Anmelden | Tozorakimab Biosimilar - Anti-IL33 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Tozorakimab Biosimilar - Anti-IL33 mAb - Research Grade | Anmelden | Tozorakimab Biosimilar - Anti-IL33 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Vulinacimab Biosimilar - Anti-VEGFR2 mAb - Research Grade | Anmelden | Vulinacimab Biosimilar - Anti-VEGFR2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Anti-MUC1/CD227(Homo sapiens) (Gatipotuzumab) Monoclonal Antibody | Anmelden | Anti-MUC1/CD227(Homo sapiens) (Gatipotuzumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-MUC1/CD227(Homo sapiens) (Gatipotuzumab) Monoclonal Antibody | Anmelden | Anti-MUC1/CD227(Homo sapiens) (Gatipotuzumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-IL17A(Homo sapiens) (Perakizumab) Monoclonal Antibody | Anmelden | Anti-IL17A(Homo sapiens) (Perakizumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-IL17A(Homo sapiens) (Perakizumab) Monoclonal Antibody | Anmelden | Anti-IL17A(Homo sapiens) (Perakizumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-TNFSF2/TNF-alpha/TNFA(Homo sapiens) (Placulumab) Monoclonal Antibody | Anmelden | Anti-TNFSF2/TNF-alpha/TNFA(Homo sapiens) (Placulumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-TNFSF2/TNF-alpha/TNFA(Homo sapiens) (Placulumab) Monoclonal Antibody | Anmelden | Anti-TNFSF2/TNF-alpha/TNFA(Homo sapiens) (Placulumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-ANGPT2/VEGFA(Homo sapiens), (Vanucizumab) Monoclonal Antibody | Anmelden | Anti-ANGPT2/VEGFA(Homo sapiens), (Vanucizumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-ANGPT2/VEGFA(Homo sapiens), (Vanucizumab) Monoclonal Antibody | Anmelden | Anti-ANGPT2/VEGFA(Homo sapiens), (Vanucizumab) Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
